The botulinum toxin market is projected to reach US$ 8,977.62 million by 2028 from US$ 5,307.71 million in 2021. It is expected to grow at a CAGR of 7.8% from 2021 to 2028.
Botulinum toxins are neurotoxins that attack nerves and cause muscle paralysis. A bacterium known as clostridium botulinum makes these neurotoxins. Healthcare providers use specific bacteria for medical injections. Injections of botulinum toxin block nerve signals to the muscle injected into it. Without a signal, the muscle cannot contract. The result is a reduction in unwanted facial lines or features. Botulinum toxin injections, such as Botox and Dysport, improve appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Botulinum Toxin Market: Strategic Insights
Market Size Value in US$ 5,307.71 Million in 2021 Market Size Value by US$ 8,977.62 Million by 2028 Growth rate CAGR of 7.8% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Botulinum Toxin Market: Strategic Insights
| Market Size Value in | US$ 5,307.71 Million in 2021 |
| Market Size Value by | US$ 8,977.62 Million by 2028 |
| Growth rate | CAGR of 7.8% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The botulinum toxin market is analyzed on the basis of product type, application, end user, and geography. By geography, the botulinum toxin market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa (MEA), and South and Central America. The botulinum toxin report offers insights and in-depth analysis of the market, emphasizing parameters, such as market trends, technological advancements, and market dynamics, along with the analysis of the competitive landscape of the world's leading market players.
Lucrative Regions for Botulinum Toxin Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Increasing Aesthetics Procedures and Use of Botulinum Toxin Drives Botulinum Toxin Market Growth
There is a significant rise in non-surgical procedures and dermal injectables across France. According to the Global Aesthetics Consensus, in 2016, ~258,438 non-surgical aesthetic procedures were performed in the country, out of which more than 101,400 were botulinum toxin (BTX) procedures. Moreover, the expansion of cosmetology clinics and the increase in the number of cosmetology practitioners are expected to drive the botulinum toxin market further in the coming years. People from countries, such as Switzerland, Romania, and Russia, visit France for aesthetic procedures due to advanced medical services available in the country.
Moreover, in Italy, every 10th patient applying for cosmetic surgery is a tourist. The Italian Association of Aesthetic Plastic Surgery (AICPE) had announced an "aesthetic alliance" with the International Society of Aesthetic Plastic Surgery (ISAPS) to develop high-quality cosmetic surgeries with enhanced patient safety. This will increase demand for botulinum toxin market.
Similarly, according to the American Society of Plastic Surgeons (ASPS), a total of 4,401,536 botulinum toxin Type A (Botox, Dysport, Xeomin) minimally-invasive cosmetic procedures were performed in the US, in which 4,136,289 were female, and 265,247 were male. In 2020, Aesthetic Neural Network (ANN) data reported total revenue of over US$ 9 billion spent on aesthetic plastic surgery. Similary, demand for botulinum toxin market will propel.
In addition, according to the American Society of Plastic Surgeons (ASPS), in 2019, the number of cosmetic procedures performed in India was 643,752. Total non-surgical procedures were 249,024, out of which botulinum toxin procedures were 70,248. Similarly, in 2019, the total number of cosmetic procedures were performed in Brazil was 2,565,675, in which total non-surgical procedures were 1,072,002—among them, botulinum toxin procedures were 507,869, leading to grow botulinum toxin market.
Therapeutic uses of BTX include treating diseases, such as chronic migraines, muscle spasticity, over-reactive bladder, and hyperhidrosis. The cosmetic and clinical application of BTX offers a comprehensive and in-depth review of aesthetic procedures and medical applications for standalone treatment, as well as combination therapy. According to ISAPS, approximately 321,702 BTX procedures were performed in Germany in 2018. Due to the increase in the geriatric population and the desire to look young, the number of BTX-based procedures being performed in Germany is rising. As per ISAPS, Germany accounts for ~4% of the total number of cosmetic procedures performed worldwide.
Moreover, there are more than 500 plastic surgeons in the UK, and the number is expected to increase in the future. Thus, with the rise in the number of aesthetic service providers, practitioners, and plastic surgeons, the number of aesthetic procedures performed in Europe is increasing, thereby boosting the demand and sales of botulinum toxin, contributing to the growth of the botulinum toxin market.
Rising Number of Non-invasive Cosmetic Procedures Contributes Significantly to Botulinum Toxin Market Growth
Cosmetic surgery and injectable BTX are among the most popular non-invasive rejuvenation procedures, and each has its unique way of improving facial aesthetics. In 2020, the BTX treatment was the leading non-invasive cosmetic procedure performed in Europe. Furthermore, in the last decade, a facial rejuvenation procedure was popular among different types of traditional surgeries in the region. The use of BTX Type A (BoNTA) in cosmetic facial treatments helps improve the aesthetics of the upper and lower face. Thus, the increasing popularity of non-invasive cosmetic procedures is triggering the demand for botulinum toxin in Europe.
According to the American Society of Plastic Surgeons (ASPS), Non-surgical Procedures, by Country in 2019
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Source: The Insight Partners Analysis, Primary Interviews, Magazines and Journals, and Secondary Sources
Non-invasive cosmetic treatments have gained popularity in recent years due to minimal downtime, no scarring, low cost, greater accuracy, and fewer complications compared to open procedures. In addition, non-invasive treatments are gaining importance due to lower post-treatment downtime. European countries are taking several initiatives to raise awareness about non-invasive aesthetic procedures. For instance, in 2019, government authorities in England launched a campaign about botched cosmetic procedures and their impact on a person's physical and mental health. Moreover, several manufacturers are working on offering more advanced non-invasive cosmetic treatment products. Therefore, the rising awareness about non-invasive cosmetic procedures and the increasing availability of user-friendly and technologically advanced non-invasive cosmetic treatment products are boosting the growth of the European botulinum toxin market.
Product Type Insights
Based on product type, the global botulinum toxin market is segmented into type A botulinum toxin and type B botulinum toxin. In 2020, the type A botulinum toxin segment held the largest share of the botulinum toxin market. Moreover, the market for the type A botulinum toxin segment is expected to grow at the highest CAGR during the period from 2021 to 2028. With a wide range of uses and a favorable safety profile, botulinum toxin A injection is a minimally invasive and promising treatment for cosmetic imperfections, muscle spasms, and other conditions. There are many uses for botulinum toxin A in treating dystonia, incontinence, migraine, blepharospasm, and hyperhidrosis. Depending on the preparation, botulinum toxin A is indicated for different diseases. Cosmetically, it treats fine lines and wrinkles on the face, particularly wrinkles on the upper face, including the forehead, side corners of the eyes, and glabellar lines.
Application Insights
Based on application, the botulinum toxin market is segmented into medical and aesthetics. The medical segment is sub-segmented as chronic migraine, muscle spasm, over-reactive bladder, hyperhidrosis, and others. The aesthetics segment is sub-segmented as Frown Lines/ Glabellar, Forehead Lines, Crow's Feet, Square Jaw/ Masseter, and Others.
The medical segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the botulinum toxin market by 2028. Botulinum toxin is a drug used to treat and manage a variety of therapeutic conditions. Chronic migraine, spastic disorders, cervical dystonia, and detrusor hyperactivity are all examples of medicinal usage. The surge in demand for the neurotoxin class of medications is bolstering this segment's market.
End-use Insights
Based on end user, the botulinum toxin market is segmented into specialty and dermatology clinics, hospitals and clinics, and others. The specialty and dermatology clinics segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Minimally invasive techniques have grown in popularity even faster than surgical procedures. Botulinum toxin (botox) injections, hyaluronic acid treatments, laser hair removal, non-surgical fat reduction, and photorejuvenation (IPL) were the five most common non-surgical cosmetic procedures in 2019, which bolstered the botulinum toxin market growth of this segment.
Botulinum Toxin Market, by Product Type – 2021 and 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Product launches and mergers and acquisitions are the highly adopted strategies by the players operating in the global botulinum toxin market. A few of the recent key product developments are listed below:
- In August 2021, Merz Therapeutics was granted the use of XEOMIN for the symptomatic treatment in children and adolescents aged 2 to 17 years of chronic sialorrhea due to neurological/neurodevelopmental disorders on the EU level.
- In December 2020, Galderma announced that Alluzience had completed its European decentralized procedure resulting in a favorable decision for the first ready-to-use neuromodulator, a wrinkle relaxing injection, in Europe. National approvals now take place across the region in line with local processes in each country.
The COVID-19 pandemic also substantially impacts aesthetic surgeries and botulinum toxin market in the region due to the closure of practices. Board-certified plastic surgeons of The American Society of Plastic Surgeons (ASPS) indicated that COVID-19 caused them to halt performing elective surgical procedures for an average of 8.1 weeks in 2020, or 15% of the year, mirroring a drop in the overall number of procedures conducted the previous year. According to the American Society of Plastic Surgeons (ASPS), the COVID-19 pandemic will result in a 15% drop in the total number of cosmetic procedures in 2020, which is roughly in line with the period practices were closed — with three of the top five procedures focusing on the face. During stay-at-home orders in 2020, minimally invasive cosmetic operations declined slightly more than surgical procedures (16% vs. 14%) for the first time in four years. The following were the top five cosmetic minimally invasive procedures performed in 2020, out of a total of 13.3 million: Type A botulinum toxin (4.4 million procedures). Beyond the COVID-19 pandemic, the market is expected to grow due to newly approved indications, the need for repeat treatments, and a largely favorable reimbursement environment, leading to a significant increase in procedure volume and botulinum toxin market sales.
Botulinum Toxin Market - Segmentation
Botulinum Toxin Market - By Product Type
- Type A Botulinum Toxin
- Type B Botulinum Toxin
Botulinum Toxin Market - By Application
- Medical
- Chronic Migraine
- Muscle Spasm
- Over Reactive Bladder
- Hyperhidrosis
- Others
- Aesthetic
- Crow's Feet
- Forehead Lines
- Frown Lines/ Glabellar
- Square Jaw/ Masseter
- Others
Botulinum Toxin Market - By Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- UAE
- Rest of the Middle East & Africa
- South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles In Botulinum Toxin Market
- AbbVie Inc.
- Merz Pharma
- Medytox
- Sanofi
- Ipsen Pharma
- Galderma
- Revance Therapeutics Inc.
- Lanzhou Institute of Biological Products Co., Ltd.
- Candela Medical
- Daewoong Pharmaceutical Co. Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Botulinum toxins are neurotoxins that attack nerves and cause muscle paralysis. A bacterium known as clostridium botulinum makes these neurotoxins. Healthcare providers use specific bacteria for medical injections. Injections of botulinum toxin block nerve signals to the muscle injected into it. Without a signal, the muscle cannot contract. The result is a reduction in unwanted facial lines or features. Botulinum toxin injections like Botox and Dysport improve the appearance by relaxing the muscles that cause wrinkles. These injections also treat migraines, hyperhidrosis, overactive bladder, and eye problems.
Key factors that are driving the growth of this market are the increasing aesthetic procedures and use of botulinum toxin and rising number of noninvasive cosmetic procedures are expected to boost the market growth for the botulinum toxins over the years.
The CAGR value of the botulinum toxins market during the forecasted period of 2021-2028 is 7.8%.
The type A botulinum toxin segment held the largest share of the market in the global botulinum toxins market in 2021.
The botulinum toxins market majorly consists of players such as AbbVie Inc., Merz Pharma, Medytox, Sanofi, Ipsen Pharma, Galderma, Revance Therapeutics Inc., Lanzhou Institute of Biological Products Co., Ltd., Candela Medical, and Daewoong Pharmaceutical Co. Ltd. amongst others.
AbbVie Inc. and Merz Pharma are the top two companies that hold huge market shares in the botulinum toxins market.
Global botulinum toxins market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. North America held the largest market share for botulinum toxins in 2021. The United States held the largest market in North America for botulinum toxins, and the market is expected to grow due to the rising aesthetic procedures, and growing development of non-invasive aesthetic procedures are projected to accelerate the growth of the botulinum toxins market.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Botulinum Toxin Market – By Product Type
1.3.2 Global Botulinum Toxin Market – By Application
1.3.3 Global Botulinum Toxin Market – By End User
1.3.4 Global Botulinum Toxin Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Botulinum Toxin Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Botulinum Toxin Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Aesthetics Procedures and Use of Botulinum Toxin
5.1.2 Rising Number of Non-invasive Cosmetic Procedures
5.2 Market Restraints
5.2.1 Side-Effects of Botulinum Toxin
5.3 Market Opportunities
5.3.1 Increasing Therapeutic Applications of Botulinum Toxin
5.4 Future Trends
5.4.1 Rise in Product Approvals
5.5 Impact Analysis
6. Botulinum Toxin Market– Global Analysis
6.1 Global Botulinum Toxin Market Revenue Forecast and Analysis
6.2 Global Botulinum Toxin Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Botulinum Toxin Market Revenue and Forecasts To 2028– by Product Type
7.1 Overview
7.2 Global Botulinum Toxin Market Revenue Share, by Product Type (2021 and 2028)
7.3 Type A Botulinum Toxin
7.3.1 Overview
7.3.2 Type A Botulinum Toxin: Global Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Type B Botulinum Toxin
7.4.1 Overview
7.4.2 Type B Botulinum Toxin: Global Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Botulinum Toxin Market Analysis – By Application
8.1 Overview
8.2 Global Botulinum Toxin Market Revenue Share, by Application (2021 and 2028)
8.3 Medical
8.3.1 Overview
8.3.2 Medical: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.1 Chronic Migraine
8.3.2.1.1 Overview
8.3.2.1.2 Chronic Migraine: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.2 Muscle Spasm
8.3.2.2.1 Overview
8.3.2.2.2 Muscle Spasm: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.3 Over Reactive Bladder
8.3.2.3.1 Overview
8.3.2.3.2 Over Reactive Bladder: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.4 Hyperhidrosis
8.3.2.4.1 Overview
8.3.2.4.2 Hyperhidrosis: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.3.2.5 Others
8.3.2.5.1 Overview
8.3.2.5.2 Others: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Aesthetic
8.4.1 Overview
8.4.2 Aesthetic: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.1 Crow’s Feet
8.4.2.1.1 Overview
8.4.2.1.2 Crow’s Feet: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.2 Forehead Lines
8.4.2.2.1 Overview
8.4.2.2.2 Forehead Lines: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.3 Frown Lines/ Glabellar
8.4.2.3.1 Overview
8.4.2.3.2 Frown Lines/ Glabellar: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.4 Square Jaw/ Masseter
8.4.2.4.1 Overview
8.4.2.4.2 Square Jaw/ Masseter: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
8.4.2.5 Others
8.4.2.5.1 Overview
8.4.2.5.2 Others: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9. Global Botulinum Toxin Market Analysis – By End User
9.1 Overview
9.2 Global Botulinum Toxin Market Revenue Share, by End User (2021 and 2028)
9.3 Specialty and Dermatology Clinics
9.3.1 Overview
9.3.2 Specialty and Dermatology Clinics: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9.4 Hospitals and Clinics
9.4.1 Overview
9.4.2 Hospitals and Clinics: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: Global botulinum toxin market– revenue and forecast to 2028 (us$ million)
10. Botulinum Toxin Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 North America: Botulinum Toxin Market
10.1.1 Overview
10.1.2 North America: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.1.3 North America: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.4 North America: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.4.1 North America: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.4.2 North America: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.5 North America: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.1.6 North America: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Country (%)
10.1.6.1 United States: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.1 United States: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.1.2 United States: Botulinum Toxin Market –Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.6.1.3 United States: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.1.3.1 United States: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.1.3.2 United States: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.1.4 United States: Botulinum Toxin Market –Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.6.2 Canada: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.2.1 Canada: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.1.6.2.2 Canada: Botulinum Toxin Market Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.1.6.2.3 Canada: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.2.3.1 Canada: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.2.3.2 Canada: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.2.4 Canada: Botulinum Toxin Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.1.6.3 Mexico: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.1 Mexico: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.1.6.3.2 Mexico: Botulinum Toxin Market – Revenue and Forecast to 2028, By Product Type (US$ Million)
10.1.6.3.3 Mexico: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.1.6.3.3.1 Mexico: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.1.6.3.3.2 Mexico: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.1.6.3.4 Mexico: Botulinum Toxin Market – Revenue and Forecast to 2028, By End User (US$ Million)
10.2 Europe: Botulinum Toxin Market
10.2.1 Overview
10.2.2 Europe: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.2.3 Europe: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.2.4 Europe: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.2.4.1 Europe: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.2.4.2 Europe: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.2.5 Europe: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.2.6 Europe: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Country (%)
10.2.6.1 Germany: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.1 Germany: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.1.2 Germany: Botulinum Toxin Market –Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.2.6.1.3 Germany: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.2.6.1.3.1 Germany: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.2.6.1.3.2 Germany: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.2.6.1.4 Germany: Botulinum Toxin Market –Revenue and Forecasts to 2028, By End User (US$ Million)
10.2.6.2 France: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.2.1 France: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.2.6.2.2 France: Botulinum Toxin Market Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.2.6.2.3 France: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.2.6.2.3.1 France: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.2.6.2.3.2 France: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.2.6.2.4 France: Botulinum Toxin Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.2.6.3 Spain: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.1 Spain: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.3.2 Spain: Botulinum Toxin Market – Revenue and Forecast to 2028, By Product Type (US$ Million)
10.2.6.3.3 Spain: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.2.6.3.3.1 Spain: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.2.6.3.3.2 Spain: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.2.6.3.4 Spain: Botulinum Toxin Market – Revenue and Forecast to 2028, By End User (US$ Million)
10.2.6.4 Italy: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.4.1 Italy: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.2.6.4.2 Italy: Botulinum Toxin Market – Revenue and Forecast to 2028, By Product Type (US$ Million)
10.2.6.4.3 Italy: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.2.6.4.3.1 Italy: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.2.6.4.3.2 Italy: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.2.6.4.4 Italy: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.2.6.5 United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.1 United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.5.2 United Kingdom: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.2.6.5.3 United Kingdom: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.2.6.5.3.1 United Kingdom: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.2.6.5.3.2 United Kingdom: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.2.6.5.4 United Kingdom: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.2.6.6 Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.1 Rest of Europe: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.2.6.6.2 Rest of Europe: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.2.6.6.3 Rest of Europe: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.2.6.6.3.1 Rest of Europe: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.2.6.6.3.2 Rest of Europe: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.2.6.6.4 Rest of Europe: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.3 Asia Pacific: Botulinum Toxin Market
10.3.1 Overview
10.3.2 Asia Pacific: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.3.3 Asia Pacific: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.3.4 Asia Pacific: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.3.4.1 Asia Pacific: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.3.4.2 Asia Pacific: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.3.5 Asia Pacific: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.3.6 Asia Pacific: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Country (%)
10.3.6.1 China: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.1 China: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.1.2 China: Botulinum Toxin Market –Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.3.6.1.3 China: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.3.6.1.3.1 China: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.3.6.1.3.2 China: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.3.6.1.4 China: Botulinum Toxin Market –Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6.2 Japan: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.2.1 Japan: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.3.6.2.2 Japan: Botulinum Toxin Market Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.3.6.2.3 Japan: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.3.6.2.3.1 Japan: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.3.6.2.3.2 Japan: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.3.6.2.4 Japan: Botulinum Toxin Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.3.6.3 India: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.1 India: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.3.2 India: Botulinum Toxin Market – Revenue and Forecast to 2028, By Product Type (US$ Million)
10.3.6.3.3 India: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.3.6.3.3.1 India: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.3.6.3.3.2 India: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.3.6.3.4 India: Botulinum Toxin Market – Revenue and Forecast to 2028, By End User (US$ Million)
10.3.6.4 South Korea: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.4.1 South Korea: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.3.6.4.2 South Korea: Botulinum Toxin Market – Revenue and Forecast to 2028, By Product Type (US$ Million)
10.3.6.5 South Korea: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.3.6.5.1.1 South Korea: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.3.6.5.1.2 South Korea: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.3.6.5.2 South Korea: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.3.6.6 Australia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.1 Australia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.6.2 Australia: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.3.6.6.3 Australia: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.3.6.6.3.1 Australia: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.3.6.6.3.2 Australia: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.3.6.6.4 Australia: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.3.6.7 Rest of Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.7.1 Rest of Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.3.6.7.2 Rest of Asia Pacific: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.3.6.7.3 Rest of Asia Pacific: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.3.6.7.3.1 Rest of Asia Pacific: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.3.6.7.3.2 Rest of Asia Pacific: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.3.6.7.4 Rest of Asia Pacific: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.4 Middle East and Africa: Botulinum Toxin Market
10.4.1 Overview
10.4.2 Middle East and Africa: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.4.3 Middle East and Africa: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.4.4 Middle East and Africa: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.4.4.1 Middle East and Africa: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.4.4.2 Middle East and Africa: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.4.5 Middle East and Africa: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.4.6 Middle East and Africa: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Country (%)
10.4.6.1 Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.1 Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.1.2 Saudi Arabia: Botulinum Toxin Market –Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.4.6.1.3 Saudi Arabia: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.4.6.1.3.1 Saudi Arabia: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.4.6.1.3.2 Saudi Arabia: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.4.6.1.4 Saudi Arabia: Botulinum Toxin Market –Revenue and Forecasts to 2028, By End User (US$ Million)
10.4.6.2 UAE: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.2.1 UAE: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.4.6.2.2 UAE: Botulinum Toxin Market Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.4.6.2.3 UAE: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.4.6.2.3.1 UAE: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.4.6.2.3.2 UAE: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.4.6.2.4 UAE: Botulinum Toxin Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.4.6.3 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.1 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.3.2 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028, By Product Type (US$ Million)
10.4.6.3.3 South Africa: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.4.6.3.3.1 South Africa: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.4.6.3.3.2 South Africa: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.4.6.3.4 South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028, By End User (US$ Million)
10.4.6.4 Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.1 Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.4.6.4.2 Rest of Middle East and Africa: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.4.6.4.3 Rest of Middle East and Africa: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.4.6.4.3.1 Rest of Middle East and Africa: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.4.6.4.3.2 Rest of Middle East and Africa: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.4.6.4.4 Rest of Middle East and Africa: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.5 South and Central America: Botulinum Toxin Market
10.5.1 Overview
10.5.2 South and Central America: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.5.3 South and Central America: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.5.4 South and Central America: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.5.4.1 South and Central America: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.5.4.2 South and Central America: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.5.5 South and Central America: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
10.5.6 South and Central America: Botulinum Toxin Market- Revenue and Forecasts to 2028, By Country (%)
10.5.6.1 Brazil: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.1 Brazil: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.1.2 Brazil: Botulinum Toxin Market –Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.5.6.1.3 Brazil: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.5.6.1.3.1 Brazil: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.5.6.1.3.2 Brazil: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.5.6.1.4 Brazil: Botulinum Toxin Market –Revenue and Forecasts to 2028, By End User (US$ Million)
10.5.6.2 Argentina: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.2.1 Argentina: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
10.5.6.2.2 Argentina: Botulinum Toxin Market Revenue and Forecasts to 2028, By Product Type (US$ Million)
10.5.6.2.3 Argentina: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.5.6.2.3.1 Argentina: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.5.6.2.3.2 Argentina: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.5.6.2.4 Argentina: Botulinum Toxin Market Revenue and Forecasts to 2028, By End User (US$ Million)
10.5.6.3 Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.1 Rest of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
10.5.6.3.2 Rest of South and Central America: Botulinum Toxin Market, By Product Type, 2019-2028 (US$ Million)
10.5.6.3.3 Rest of South and Central America: Botulinum Toxin Market, By Application, 2019-2028 (US$ Million)
10.5.6.3.3.1 Rest of South and Central America: Botulinum Toxin Market, by Medical, 2019–2028 (US$ Million)
10.5.6.3.3.2 Rest of South and Central America: Botulinum Toxin Market, by Aesthetic, 2019–2028 (US$ Million)
10.5.6.3.4 Rest of South and Central America: Botulinum Toxin Market, By End User, 2019-2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on Botulinum Toxin Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Botulinum Toxin Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 AbbVie Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merz Pharma
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Medytox
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Sanofi
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Ipsen Pharma
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Galderma
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Revance Therapeutics Inc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Lanzhou Institute of Biological Products Co., Ltd.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Candela Medical
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 DAEWOONG PHARMACEUTICAL CO., LTD
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. According to the American Society of Plastic Surgeons (ASPS), Nonsurgical Procedures, by Country in 2019
Table 2. North America: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 5. North America: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 6. North America: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 7. United States: Botulinum Toxin Market, By Product Type -Revenue and Forecast to 2028 (US$ Million)
Table 8. United States: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 9. United States: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 10. United States: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 11. United States: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 12. Canada: Botulinum Toxin Market, By Product Type - Revenue and Forecasts to 2028 (US$ Million)
Table 13. Canada: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 14. Canada: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 15. Canada: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 16. Canada: Botulinum Toxin Market, By End User - Revenue and Forecasts to 2028 (US$ Million)
Table 17. Mexico: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 18. Mexico: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 19. Mexico: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 20. Mexico: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 21. Mexico: Botulinum Toxin Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 22. Europe: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 23. Europe: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 24. Europe: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 25. Europe: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 26. Europe: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 27. Germany: Botulinum Toxin Market, By Product Type -Revenue and Forecast to 2028 (US$ Million)
Table 28. Germany: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 29. Germany: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 30. Germany: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 31. Germany: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 32. France: Botulinum Toxin Market, By Product Type - Revenue and Forecasts to 2028 (US$ Million)
Table 33. France: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 34. France: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 35. France: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 36. France: Botulinum Toxin Market, By End User - Revenue and Forecasts to 2028 (US$ Million)
Table 37. Spain: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 40. Spain: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain: Botulinum Toxin Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 42. Italy: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 43. Italy: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 44. Italy: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 45. Italy: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 46. Italy: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 47. United Kingdom: Botulinum Toxin Market, By Product Type - Revenue and Forecasts To 2028 (US$ Million)
Table 48. United Kingdom: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 49. United Kingdom: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 50. United Kingdom: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 51. United Kingdom: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 52. Rest Of Europe: Botulinum Toxin Market, By Product Type- Revenue and Forecasts to 2028 (US$ Million)
Table 53. Rest of Europe: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 54. Rest of Europe: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 55. Rest of Europe: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 56. Rest Of Global Botulinum Toxin Market, By End User- Revenue and Forecasts to 2028 (US$ Million)
Table 57. Asia Pacific: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 58. Asia Pacific: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 59. Asia Pacific: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 60. Asia Pacific: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 61. Asia Pacific: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 62. China: Botulinum Toxin Market, By Product Type -Revenue and Forecast to 2028 (US$ Million)
Table 63. China: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 64. China: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 65. China: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 66. China: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 67. Japan: Botulinum Toxin Market, By Product Type - Revenue and Forecasts to 2028 (US$ Million)
Table 68. Japan: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 69. Japan: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 70. Japan: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 71. Japan: Botulinum Toxin Market, By End User - Revenue and Forecasts to 2028 (US$ Million)
Table 72. India: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 73. India: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 74. India: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 75. India: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 76. India: Botulinum Toxin Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 77. South Korea: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 78. South Korea: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 79. South Korea: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 80. South Korea: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 81. South Korea: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 82. Australia: Botulinum Toxin Market, By Product Type - Revenue and Forecasts To 2028 (US$ Million)
Table 83. Australia: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 84. Australia: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 85. Australia: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 86. Australia: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 87. Rest Of Asia Pacific: Botulinum Toxin Market, By Product Type- Revenue and Forecasts to 2028 (US$ Million)
Table 88. Rest of Asia Pacific: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 89. Rest of Asia Pacific: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 90. Rest of Asia Pacific: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest Of Asia Pacific: Botulinum Toxin Market, By End User- Revenue and Forecasts to 2028 (US$ Million)
Table 92. Middle East and Africa: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 93. Middle East and Africa: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 94. Middle East and Africa: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 95. Middle East and Africa: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 96. Middle East and Africa: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 97. Saudi Arabia: Botulinum Toxin Market, By Product Type -Revenue and Forecast to 2028 (US$ Million)
Table 98. Saudi Arabia: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 99. Saudi Arabia: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 100. Saudi Arabia: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 101. Saudi Arabia: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 102. UAE: Botulinum Toxin Market, By Product Type - Revenue and Forecasts to 2028 (US$ Million)
Table 103. UAE: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 104. UAE: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 105. UAE: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 106. UAE: Botulinum Toxin Market, By End User - Revenue and Forecasts to 2028 (US$ Million)
Table 107. South Africa: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 108. South Africa: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 109. South Africa: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 110. South Africa: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 111. South Africa: Botulinum Toxin Market, By End User– Revenue and Forecast to 2028 (US$ Million)
Table 112. Rest Of Middle East and Africa: Botulinum Toxin Market, By Product Type- Revenue and Forecasts to 2028 (US$ Million)
Table 113. Rest of Middle East and Africa: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 114. Rest of Middle East and Africa: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 115. Rest of Middle East and Africa: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 116. Rest Of Middle East and Africa: Botulinum Toxin Market, By End User- Revenue and Forecasts to 2028 (US$ Million)
Table 117. South and Central America: Botulinum Toxin Market, By Product Type – Revenue and Forecast to 2028 (US$ Million)
Table 118. South and Central America: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 119. South and Central America: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 120. South and Central America: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 121. South and Central America: Botulinum Toxin Market, By End User – Revenue and Forecast to 2028 (US$ Million)
Table 122. Brazil: Botulinum Toxin Market, By Product Type -Revenue and Forecast to 2028 (US$ Million)
Table 123. Brazil: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 124. Brazil: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 125. Brazil: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 126. Brazil: Botulinum Toxin Market, By End User - Revenue and Forecasts To 2028 (US$ Million)
Table 127. Argentina: Botulinum Toxin Market, By Product Type - Revenue and Forecasts to 2028 (US$ Million)
Table 128. Argentina: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 129. Argentina: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 130. Argentina: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 131. Argentina: Botulinum Toxin Market, By End User - Revenue and Forecasts to 2028 (US$ Million)
Table 132. Rest Of South and Central America: Botulinum Toxin Market, By Product Type- Revenue and Forecasts to 2028 (US$ Million)
Table 133. Rest of South and Central America: Botulinum Toxin Market, By Application – Revenue and Forecast to 2028 (US$ Million)
Table 134. Rest of South and Central America: Botulinum Toxin Market, By Medical – Revenue and Forecast To 2028 (US$ Million)
Table 135. Rest of South and Central America: Botulinum Toxin Market, By Aesthetic – Revenue and Forecast to 2028 (US$ Million)
Table 136. Rest Of South and Central America: Botulinum Toxin Market, By End User- Revenue and Forecasts to 2028 (US$ Million)
Table 137. Organic Developments Done by Companies
Table 138. Inorganic Developments Done by Companies
Table 139. Glossary of Terms
LIST OF FIGURES
Figure 1. Botulinum Toxin Market Segmentation
Figure 2. Botulinum Toxin Market, By Region
Figure 3. Global Botulinum Toxin Market Overview
Figure 4. Type A Botulinum Toxin Segment Held Largest Share of Product Type Segment in Botulinum Toxin Market
Figure 5. North America is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Botulinum Toxin Market, by Geography (US$ Million)
Figure 7. Global Botulinum Toxin Market- Leading Country Markets (US$ Million)
Figure 8. Global Botulinum Toxin Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Global Botulinum Toxin Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 16. Global Botulinum Toxin Market – By Geography Forecast and Analysis – 2021 - 2028
Figure 17. Market Positioning of Key Players in Global Botulinum Toxin Market
Figure 18. Global Botulinum Toxin Market Revenue Share, by Product Type (2021 and 2028)
Figure 19. Type A Botulinum Toxin: Global Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Type B Botulinum Toxin: Global Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Global Botulinum Toxin Market Revenue Share, by Application (2021 and 2028)
Figure 22. Medical: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 23. Chronic Migraine: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 24. Muscle Spasm: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 25. Over Reactive Bladder: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 26. Hyperhidrosis: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 28. Aesthetic: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 29. Crow’s Feet: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 30. Forehead Lines: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Frown Lines/ Glabellar: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Square Jaw/ Masseter: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Others: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 34. Global Botulinum Toxin Market Revenue Share, by End User (2021 and 2028)
Figure 35. Specialty and Dermatology Clinics: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36. Hospitals and Clinics: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 37. Others: Global Botulinum Toxin Market– Revenue and Forecast to 2028 (US$ Million)
Figure 38. North America: Botulinum Toxin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 39. North America: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 40. North America: Botulinum Toxin Market -Revenue and Forecasts to 2028, By Country (%)
Figure 41. United States: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 42. Canada: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 43. Mexico: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 44. Europe: Botulinum Toxin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 45. Europe: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 46. Europe: Botulinum Toxin Market -Revenue and Forecasts to 2028, By Country (%)
Figure 47. Germany: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. France: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Spain: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Italy: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 51. United Kingdom: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Rest Of Europe: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 53. Asia Pacific: Botulinum Toxin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 54. Asia Pacific: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Asia Pacific: Botulinum Toxin Market -Revenue and Forecasts to 2028, By Country (%)
Figure 56. China: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. Japan: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 58. India: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. South Korea: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 60. Australia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Rest Of Asia Pacific: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 62. Middle East and Africa: Botulinum Toxin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 63. Middle East and Africa: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 64. Middle East and Africa: Botulinum Toxin Market -Revenue and Forecasts to 2028, By Country (%)
Figure 65. Saudi Arabia: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. UAE: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 67. South Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. Rest of Middle East and Africa: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 69. South and Central America: Botulinum Toxin Market, by Key Country – Revenue (2021) (US$ Million)
Figure 70. South and Central America: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 71. South and Central America: Botulinum Toxin Market -Revenue and Forecasts to 2028, By Country (%)
Figure 72. Brazil: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 73. Argentina: Botulinum Toxin Market - Revenue and Forecasts to 2028 (US$ Million)
Figure 74. Rest Of South and Central America: Botulinum Toxin Market – Revenue and Forecast to 2028 (US$ Million)
Figure 75. Impact of COVID-19 Pandemic in North American Country Markets
Figure 76. Impact of COVID-19 Pandemic in European Country Markets
Figure 77. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 78. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 79. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Figure 80. Growth Strategies Done by the Companies in the Market, (%)
The List of Companies - Botulinum Toxin Market
- AbbVie Inc.
- Merz Pharma
- Medytox
- Sanofi
- Ipsen Pharma
- Galderma
- Revance Therapeutics Inc.
- Lanzhou Institute of Biological Products Co., Ltd.
- Candela Medical
- Daewoong Pharmaceutical Co., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Botulinum Toxin Market
Feb 2022
Aquatic Veterinary Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Diagnostics and Treatments), Species (Fish, Crustaceans, Mollusca, and Others), Disease Source (Bacteria, Viruses, Parasites, and Others), Route of Administration (Water Medication, Medicated Feed, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis By Treatment (Generic Drugs and Originators), Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2022
Malaria and Sickle Cell Disease Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Treatment [Malaria and Sickle Cell Disease (SCD)], Route of Administration (Oral and Parenteral), and Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Others)
Feb 2022
Pharmaceutical Contract Sales Organizations Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Services (Commercial Services and Non-Commercial Services), Modules (Syndicated Modules and Dedicated Modules), Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, and Others), End User (Biopharmaceutical Companies and Pharmaceutical Companies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Breast Cancer Therapeutics Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Drug Therapy [Targeted Drug Therapy (Abemaciclib, Ado-Trastuzumab Emtansine, Palbociclib, Trastuzumab, and Other Target Drug Therapies), Hormonal Drug Therapy (Selective Estrogen Receptor Modulators, Aromatase Inhibitors, and Selective Estrogen Receptor Downregulators), Chemotherapy, and Immunotherapy/Biological Therapy], Breast Cancer Type (Hormone Receptor, HER2+, and Triple-Negative Breast Cancer), Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, and Online Pharmacies), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Feb 2022
Radioactive Tracer Market
Size and Forecast to 2030 - Global Analysis by Tracer Type [Technetium-99m & Tc-97m, Iodine-131, Iron-59, Lutetium-171, Rubidium (Rb-82) Chloride & Ammonia (N-13), Scandium-46, Seaborgium-269, Hassium-269, Gallium Citrate Ga 67, Prostate-Specific Membrane Antigen (PSMA) (Ga-68), FDDNP (F-18) & FDOPA (F-18), Phosphorus-32 & Chromium-51, Thallium-201, F-18 FDG, F-18 FAPI, Ga-68 FAPI, F-18 PSMA, DOTATOC/DOTANOC/DOTATATE (Ga-68), and Others], Test Type (PET, SPECT, and Others), Application (Oncology, Pulmonary, Neurology, Cardiology, and Others) End User (Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutes, And Others), and Geography
Feb 2022
Glioma Treatment Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease (Astrocytoma, Oligoastrocytoma, and Oligodendroglioma), Treatment Type (Surgery, Chemotherapy, Radiation Therapy, and Others), Grade (Low Grade and High Grade), End User (Hospital & Clinics and Ambulatory Surgical Center), and Geography
Feb 2022
Hyperpigmentation Disorder Treatment Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Treatment Type (Cosmeceutical, Light or Laser Therapy, Microdermabrasion, Chemical Peels, Cryotherapy, and Others), Condition (Melasma, Solar Lentigines, Post-Inflammatory Hyperpigmentation, and Others), End User (Hospitals, Dermatology Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)